| dc.contributor.author | Başaran, Özcan | |
| dc.contributor.author | Başaran, Nesrin Filiz | |
| dc.contributor.author | Cekic, Edip Guvenc | |
| dc.contributor.author | Biteker, Murat | |
| dc.date.accessioned | 2020-11-20T16:17:38Z | |
| dc.date.available | 2020-11-20T16:17:38Z | |
| dc.date.issued | 2015 | |
| dc.identifier.issn | 1060-0280 | |
| dc.identifier.issn | 1542-6270 | |
| dc.identifier.uri | https://doi.org/10.1177/1060028014555860 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12809/3286 | |
| dc.description | WOS: 000346647000020 | en_US |
| dc.description | PubMed ID: 25524932 | en_US |
| dc.item-language.iso | eng | en_US |
| dc.publisher | Sage Publications Inc | en_US |
| dc.item-rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Criteria for Prescribing Dabigatrin Extexilate and Rivaroxaban Really Appropriate? Comment | en_US |
| dc.item-type | letter | en_US |
| dc.contributor.department | MÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| dc.contributor.institutionauthor | Başaran, Özcan | |
| dc.identifier.doi | 10.1177/1060028014555860 | |
| dc.identifier.volume | 49 | en_US |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.startpage | 154 | en_US |
| dc.identifier.endpage | 154 | en_US |
| dc.relation.journal | Annals of Pharmacotherapy | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
